This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of active pharmaceutical ingredients (APIs). It is particularly significant in the development of drugs targeting the central nervous system, where its chiral structure plays a crucial role in enhancing specificity and efficacy. The trifluoro and fluoro substituents contribute to the compound’s stability and bioavailability, making it suitable for use in the production of antidepressants, antipsychotics, or other neuroactive agents. Additionally, its hydrochloride salt form improves solubility, facilitating easier formulation into oral or injectable medications. Researchers also explore its potential in creating novel therapeutic agents for treating neurological disorders due to its unique structural properties.